- $26.27m
- $39.77m
- $65.27m
Cosmos Health Q3 revenue rises as gross margin improves
Brief: Cosmos Health Q3 Adjusted EBITDA USD 4.63 Million
Brief: Cosmos Health Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Brief: Cosmos Health Invests Additional $200,000 In Ethereum
Brief: Cosmos Health Inc - Purchases Additional $500,000 Of Ethereum
Brief: Cosmos Health Expands Order Book With Contract Manufacturing Agreement With Medical Pharmaquality
Brief: Cosmos Health Expands Presence In The $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement With Scientific Pharmacy
Brief: Cosmos Health Q2 Gross Profit USD 1.16 Million
Brief: Cosmos Health Issues & Sells $300 Mln In Senior Secured Convertible Promissory Notes
Brief: Cosmos Health To Start US Production At GMP-Certified Facilities
Brief: Cosmos Health Q1 Adjusted EBITDA USD 370 Thousand
Brief: Cosmos Health Q1 Revenue USD 13.71 Million
Brief: Cosmos Health Receives Additional 180-Day Compliance Period From Nasdaq
Brief: Cosmos Health Announces It Will Not Proceed With An Offering Under Its Form S-1
Brief: Cosmos Health Signs Expanded Exclusive Distribution Agreement With Virax Biolabs For Avian Influenza Virus PCR Kits
Brief: Cosmos Health Files For Offering Of Up To 10.7 Mln Shares Of Common Stock
Cosmos Health Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Cosmos Health Q3 Adjusted EBITDA USD -700 Thousand
Advisory: Alert incorrectly tagged to Cosmic CRF Ltd withdrawn